NW Bio granted cell production patent 

Northwest Biotherapeutics Inc., of Bethesda, a biotechnology company developing personalized immune therapies for solid tumor cancers, announced that it has been issued a U.S. patent covering novel processes for manufacturing human dendritic cells.

E-Mail Newsroom


Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • HTML tags will be transformed to conform to HTML standards.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.